Source of Publication
Frontiers in Molecular Neuroscience
© Copyright © 2020 Ali, Shah, Zeb, Malik, Alvi, Alkury, Rashid, Hussain, Ullah, Ullah Khan, Koh and Li. Stroke is the leading cause of morbidity and mortality worldwide. About 87% of stroke cases are ischemic, which disrupt the physiological activity of the brain, thus leading to a series of complex pathophysiological events. Despite decades of research on neuroprotectants to probe for suitable therapies against ischemic stroke, no successful results have been obtained, and new alternative approaches are urgently required in order to combat this pathological torment. To address these problems, drug repositioning/reprofiling is explored extensively. Drug repurposing aims to identify new uses for already established drugs, and this makes it an attractive commercial strategy. Nuclear factor-kappa beta (NF-κB) is reported to be involved in many physiological and pathological conditions, such as neurodegeneration, neuroinflammation, and ischemia/reperfusion (I/R) injury. In this study, we examined the neuroprotective effects of atorvastatin, cephalexin, and mycophenolate against the NF-κB in ischemic stroke, as compared to the standard NF-κB inhibitor caeffic acid phenethyl ester (CAPE). An in-silico docking analysis was performed and their potential neuroprotective activities in the in vivo transient middle cerebral artery occlusion (t-MCAO) rat model was examined. The percent (%) infarct area and 28-point composite neuro score were examined, and an immunohistochemical analysis (IHC) and enzyme-linked immunosorbent assay (ELISA) were further performed to validate the neuroprotective role of these compounds in stroke as well as their potential as antioxidants. Our results demonstrated that these novels NF-κB inhibitors could attenuate ischemic stroke-induced neuronal toxicity by targeting NF-κB, a potential therapeutic approach in ischemic stroke.
Frontiers Media S.A.
Chemistry | Computer Sciences | Medicine and Health Sciences
atorvastatin, caeffic acid phenethyl ester, cephalexin, MCAO stroke, mycophenolate, p-NF-κB, reprofiling
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ali, Awais; Shah, Fawad Ali; Zeb, Alam; Malik, Imran; Alvi, Arooj Mohsin; Alkury, Lina Tariq; Rashid, Sajid; Hussain, Ishtiaq; Ullah, Najeeb; Khan, Arif Ullah; Koh, Phil Ok; and Li, Shupeng, "NF-κB Inhibitors Attenuate MCAO Induced Neurodegeneration and Oxidative Stress—A Reprofiling Approach" (2020). All Works. 2507.
Indexed in Scopus
Open Access Type
Gold: This publication is openly available in an open access journal/series